Rad52 Antibodies

Santa Cruz Biotechnology provides a broad selection of Rad52 monoclonal antibodies for research in understanding DNA repair mechanisms. Rad52 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Rad52 plays a crucial role in homologous recombination and DNA double-strand break repair, making it essential for maintaining genomic stability. The function of Rad52 is particularly significant in cellular responses to DNA damage, which can have implications in cancer research and therapeutic development. Understanding Rad52 can provide insights into the mechanisms of tumorigenesis and the development of resistance to DNA-damaging agents. Studying Rad52 interactions helps reveal key aspects of DNA repair pathways and their regulation in various cellular conditions. Research focusing on Rad52 continues to uncover new aspects of genome maintenance and stability. Investigating Rad52 mechanisms contributes to developing novel therapeutic strategies for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies for Rad52 support researchers worldwide in advancing our understanding of DNA repair processes and their impact on human health.